Boots has confirmed it will start offering a new medical cannabis prescription service for people in the UK living with three types of health conditions. Boots Online Doctor announced on November 16 the launch of SureLeaf, a specialist medical cannabis service.
The new service expands the range of specialist healthcare available through Boots Online Doctor, giving those eligible another treatment option to consider, greater access to clinical expertise, a consultant-led assessment and ongoing clinical care.
Who is eligible for the service?
Patients aged 25 or over with an eligible condition can begin their assessment online, which will then be reviewed by the clinical team before arranging a video consultation with a consultant in the relevant medical speciality.
The service will support people living with chronic pain conditions including chronic primary and neuropathic pain, fibromyalgia, complex regional pain syndrome, chronic back or neck pain, osteoarthritis, rheumatoid arthritis, sciatica, peripheral neuropathy, trigeminal neuralgia, phantom limb pain, chronic migraine, endometriosis-related pelvic pain and chronic abdominal or pancreatic pain. It will also support people with generalised anxiety disorder and insomnia disorder.
Clinical safeguards and ongoing care
Any proposed prescription will be independently reviewed by a multidisciplinary clinical team which includes a second, independent consultant, before treatment begins. Patients must have already tried conventional treatments without achieving adequate symptom relief.
Once treatment begins, patients will receive ongoing clinical support and monitoring, including an initial review after 28 days followed by reviews at least every three months. Validated questionnaires will be used throughout treatment to assess relevant areas, including quality of life, pain, anxiety, sleep, and mood, helping clinicians monitor treatment effectiveness.
Jamie Kerruish, Chief Healthcare Officer at Boots, said: "At Boots, we're committed to making healthcare more accessible and helping people find the right support for their individual needs. Millions of people live with ongoing pain and for some, conventional treatments do not provide adequate symptom relief."
Research partnership with University of Nottingham
Alongside the launch, Boots and the University of Nottingham are exploring a collaborative research programme to build on the existing real-world evidence and understanding of medical cannabis in chronic pain management. The work would build on the existing partnership between the two organisations, which is based on a shared commitment to improve patient care through evidence-led innovation.
SureLeaf will operate as a private healthcare service through Boots Online Doctor. Dr David Gwynne, Medical Director at Boots Online Doctor, said: "Medical cannabis is not appropriate for everyone and prescribing decisions need to be made carefully on an individual patient basis."